KXA
RPID icon

KPCB XIII Associates’s Rapid Micro Biosystems RPID Stock Holding History

KPCB XIII Associates’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$598K Buy
+32,400
New +$669K 0.12% 5

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

KPCB XIII Associates's RPID Position: Q3 2021 in Review

KPCB XIII Associates opened a new position in Rapid Micro Biosystems (RPID) in Q3 2021: 32,400 shares worth $598K. The stake represents 0.12% of the portfolio and ranks #5 among its holdings.

49 funds tracked by Wall St. Rank hold RPID as of Q3 2021.

  • KPCB XIII Associates held 32,400 shares of Rapid Micro Biosystems worth $598K as of Q3 2021.
  • Rapid Micro Biosystems was a new KPCB XIII Associates position in Q3 2021.
  • Rapid Micro Biosystems made up 0.12% of KPCB XIII Associates's portfolio in Q3 2021, its #5 holding.
  • 49 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q3 2021.

Based on KPCB XIII Associates's 13F filing for Q3 2021, filed 25 Oct 2021.